Synthesis, biological evaluation and preliminary mechanisms of 6-amino substituted harmine derivatives as potential antitumor agents. 2022

Dongyan Hu, and Guangtian Han, and Huazhong Ren, and Xinwei Li, and Xi'an Li, and Lirong Yue, and Jiao Xu, and Jiafu Feng, and Li Guo
Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; Genuine Medicinal Material Engineering Research Center of Leshan, Department of Pharmacy, Leshan Vocational & Technical College, Leshan 614000, China.

To explore the effect of the introduction of the amino and substituted amino groups on the antitumor activity of harmine, twenty-five novel 6-amino substituted harmine derivatives (3a-3j and 5a-5o) were synthesized and evaluated for anti-proliferative activity on a panel of cancer cell lines. Compounds 3i and 5n exhibited the most potent antiproliferative activity with IC50 values lower than 2.2 μM. Especially, compound 5n possessed extremely potent antitumor activity with IC50 values of 0.34 μM and 0.65 μM against HL-60 and A549 cell lines, respectively. Further, the preliminary studies of mechanisms showed that compound 5n could significantly induce cell apoptosis in a dose-dependent manner, cause cell cycle arrest at the G2/M phase and intercalate into ct-DNA via the competition with EB, while displaying very weak topoisomerase I (Topo I) inhibition activity. More importantly, 5n showed mild cytotoxicity against human normal lung epithelial cells BEAS-2B. Based on these considerations, 5n may be a good antitumor candidate compound for further exploration.

UI MeSH Term Description Entries
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006247 Harmine Alkaloid isolated from seeds of PEGANUM HARMALA; ZYGOPHYLLACEAE. It is identical to banisterine, or telepathine, from Banisteria caapi and is one of the active ingredients of hallucinogenic drinks made in the western Amazon region from related plants. It has no therapeutic use, but (as banisterine) was hailed as a cure for postencephalitic PARKINSON DISEASE in the 1920's. 9H-Pyrido(3,4-b)indole, 7-methoxy-1-methyl-,Banisterine,Leucoharmine,Telepathine,Yageine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular

Related Publications

Dongyan Hu, and Guangtian Han, and Huazhong Ren, and Xinwei Li, and Xi'an Li, and Lirong Yue, and Jiao Xu, and Jiafu Feng, and Li Guo
August 2016, Bioorganic & medicinal chemistry letters,
Dongyan Hu, and Guangtian Han, and Huazhong Ren, and Xinwei Li, and Xi'an Li, and Lirong Yue, and Jiao Xu, and Jiafu Feng, and Li Guo
September 2016, Scientific reports,
Dongyan Hu, and Guangtian Han, and Huazhong Ren, and Xinwei Li, and Xi'an Li, and Lirong Yue, and Jiao Xu, and Jiafu Feng, and Li Guo
June 2022, Bioorganic & medicinal chemistry letters,
Dongyan Hu, and Guangtian Han, and Huazhong Ren, and Xinwei Li, and Xi'an Li, and Lirong Yue, and Jiao Xu, and Jiafu Feng, and Li Guo
September 2014, European journal of medicinal chemistry,
Dongyan Hu, and Guangtian Han, and Huazhong Ren, and Xinwei Li, and Xi'an Li, and Lirong Yue, and Jiao Xu, and Jiafu Feng, and Li Guo
February 2013, European journal of medicinal chemistry,
Dongyan Hu, and Guangtian Han, and Huazhong Ren, and Xinwei Li, and Xi'an Li, and Lirong Yue, and Jiao Xu, and Jiafu Feng, and Li Guo
June 2013, European journal of medicinal chemistry,
Dongyan Hu, and Guangtian Han, and Huazhong Ren, and Xinwei Li, and Xi'an Li, and Lirong Yue, and Jiao Xu, and Jiafu Feng, and Li Guo
January 2019, Medicinal chemistry (Shariqah (United Arab Emirates)),
Dongyan Hu, and Guangtian Han, and Huazhong Ren, and Xinwei Li, and Xi'an Li, and Lirong Yue, and Jiao Xu, and Jiafu Feng, and Li Guo
June 2022, Molecules (Basel, Switzerland),
Dongyan Hu, and Guangtian Han, and Huazhong Ren, and Xinwei Li, and Xi'an Li, and Lirong Yue, and Jiao Xu, and Jiafu Feng, and Li Guo
March 2011, Molecules (Basel, Switzerland),
Dongyan Hu, and Guangtian Han, and Huazhong Ren, and Xinwei Li, and Xi'an Li, and Lirong Yue, and Jiao Xu, and Jiafu Feng, and Li Guo
December 2011, European journal of medicinal chemistry,
Copied contents to your clipboard!